Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Emergent BioSolutions Inc. (NYSE: EBS)
EBS Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-13.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-24.30%
EBS Stock Analysis
EBS
PE Ratio:
EBS
PEG Ratio:
Not Available
EBS
Forward EPS Growth (12 month):
0.00%
EBS
PS Ratio:
0.6
EBS
PSG Ratio:
-0.1
EBS
Forward Revenue Growth (12 month):
-8.30%
EBS Articles
No data was found